(Q39017073)

8 September 2017

title

miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc (English)

1 reference

8 September 2017

0 references

Weiling He

1

1 reference

8 September 2017

Yuhuang Li

2

1 reference

8 September 2017

Xinlin Chen

3

1 reference

8 September 2017

Liya Lu

4

1 reference

8 September 2017

Bin Tang

5

1 reference

8 September 2017

Zhixiong Wang

6

1 reference

8 September 2017

Yunbao Pan

7

1 reference

8 September 2017

Shirong Cai

8

1 reference

8 September 2017

Yulong He

9

1 reference

8 September 2017

Zunfu Ke

10

1 reference

8 September 2017

publication date

1 January 2014

1 reference

Journal of Gastroenterology and Hepatology

8 September 2017

published in

1 reference

8 September 2017

volume

29

1 reference

8 September 2017

issue

7

1 reference

8 September 2017

page(s)

1427-1434

1 reference

Polycomb Regulates NF-κB Signaling in Cancer through miRNA

8 September 2017

cites work

1 reference

Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding

21 January 2018

1 reference

Delivering the promise of miRNA cancer therapeutics

21 January 2018

1 reference

The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease

21 January 2018

1 reference

miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients

21 January 2018

1 reference

miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways

21 January 2018

1 reference

A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

21 January 2018

1 reference

Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.

21 January 2018

1 reference

MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas

21 January 2018

1 reference

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

Dysregulation of microRNAs in cancer: playing with fire

21 January 2018

1 reference

The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort: comparative analysis of the sixth and seventh TNM editions in patients with gastric cancer from Japan and the United Kingdom.

21 January 2018

1 reference

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation

21 January 2018

1 reference

MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer

21 January 2018

1 reference

MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint.

21 January 2018

1 reference

α1-Adrenergic receptors mediate combined signals initiated by mechanical stretch stress and norepinephrine leading to accelerated mouse vein graft atherosclerosis

21 January 2018

1 reference

Simvastatin inhibits the additive activation of ERK1/2 and proliferation of rat vascular smooth muscle cells induced by combined mechanical stress and oxLDL through LOX-1 pathway

21 January 2018

1 reference

Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs

21 January 2018

1 reference

Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma

21 January 2018

1 reference

Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer.

21 January 2018

1 reference

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements

21 January 2018

1 reference

MYC on the path to cancer

21 January 2018

1 reference

Therapeutic targeting of Myc-reprogrammed cancer cell metabolism

21 January 2018

1 reference

MYC deregulation in gastric cancer and its clinicopathological implications.

21 January 2018

1 reference

Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma

21 January 2018

1 reference

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

21 January 2018

1 reference

MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis

21 January 2018

1 reference

Rho GTPases in cell biology

21 January 2018

1 reference

MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation

21 January 2018

1 reference

Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression

21 January 2018

1 reference

Amplification and expression of the c-myc oncogene in human lung cancer cell lines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12558

1 reference

8 September 2017

1 reference